NCT06217536 Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas Status WITHDRAWN Phase PHASE1/PHASE2
NCT06182410 Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma Status WITHDRAWN Phase PHASE2
NCT06143839 VYxeoS Liposomal Italian Observational Study iN the Real Practice Status COMPLETED Phase N/A
NCT06113237 Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy Status RECRUITING Phase N/A
NCT06108050 JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06043427 Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma Status RECRUITING Phase PHASE2
NCT05974293 A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders Status WITHDRAWN Phase PHASE2
NCT05875974 A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy Status COMPLETED Phase PHASE4
NCT05869773 A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy Status COMPLETED Phase PHASE4
NCT05864846 A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex Status COMPLETED Phase PHASE4
NCT05826756 Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting Status RECRUITING Phase N/A
NCT05772429 Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05734066 Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma Status RECRUITING Phase PHASE1/PHASE2
NCT05733390 A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder Status WITHDRAWN Phase PHASE2
NCT05720494 A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05656248 Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms Status ACTIVE_NOT_RECRUITING Phase PHASE2